Background: Laminin-5 (ln-5), a large heterotrimeric
Introduction
Laminin-5 (In-5; previously called epiligrin, kalinin, nicein, and ladsin) is a large basement membrane glycoprotein involved in anchoring, functional determination, and migration of certain epithelial cells. It is a heterotrimeric protein composed of an a3, f33, and y2 chain, which represent the products of three different genes (1) . The molecule binds to and functions as a ligand for the desmosomal integrin a6,34, as well as the focal adhesion integrin a3,31 (2) (3) (4) (5) .
The role of in adhesion was first noted by the rounding and detachment of adherent cultured epithelial cells induced by mAb BM165, an antibody to the In a3 chain (6) . Mutations in any of the three In-S chains can cause Herlitz syndrome (H-JEB), a severe form of the blistering skin disease junctional epidermolysis bullosa, in which the squamous epithelium detaches from underlying mesenchyme (7) (8) (9) . The morphogenic activity of In-5 has been recently observed in experiments involving MCF-1 OA mammary epithelial cells. Antibodies that block the function of In-5 inhibited hemidesmosome assembly and the branching morphogenesis induced by matrigel (10) .
The role of In-5 in cellular migration appears enigmatic. In multiple studies In- 5 has been described as a strong migration-promoting factor (11) (12) (13) (14) (15) , whereas in other studies it has been shown to act as a locomotion brake (16, 17) . For example, a protein originally named ladsin and subsequently found to be identical to In-S (18) , induced the attachment and migration of a wide variety of cell lines including nontumorigenic epithelial, endothelial, and fibroblastic cell lines and several cancer cell lines (12, 19) . On the other hand, cultured H-JEB keratinocytes with a homozygous null In y2 gene have been reported to exhibit enhanced motility in vitro, which is then reduced in transfected cells that re-express In y2 (16) . Since cell migration is a complex process that involves a series of attachment and disengagement events, different aspects of the process may have been observed in the different studies. Recent work, which may tie together these apparently contradictory reports, has shown that the treatment of a ln-5 matrix with metalloproteinase 2 (MMP-2) or with tissue-type plasminogen activator (tPA) modifies ln-5 and changes its migratory properties (11, 20) . MMP-2 cleaves the In y2 chain to expose a putative cryptic migratory signal (1 1), while tPA cleaves the In a3 chain to generate a form of In-5 that supports hemidesmosome assembly and inhibits motility (20) . These proteases have tissue-specific patterns of expression that may explain the different functional consequences of ln-5 expression (20) .
Ln-5 also appears to play dual roles in tumor progression. In gliomas and in carcinomas of the colon, gastric system, and squamous epithelium, it has been described as a highly expressed -narker for the proliferating tumor cells that are located at the invasive edge of the tumor (15, (21) (22) (23) . Its expression was induced in cell lines derived from these tumor types by the tumor promoters tissue plasminogen activator (TPA) and epidermal growth factor (EGF) (18) . On the other hand, in basal cell and prostate carcinomas, ln-5 expression has been reported to be reduced relative to normal tissue (24) (25) (26) Human breast epithelial cells were sorted from primary cultures of breast mammoplasty specimens using a combination of calcium-free medium and immunomagnetic separation techniques (33) . Normal breast epithelial cell strains 81N, 76N, and 70N were isolated from mammoplasty specimens (34) . To prepare quiescent cells, 76N cells were plated at approximately 15 % confluence and grown to confluence. To prepare senescent cells, 76N cells were passaged until proliferation ceased, for 20 to 22 passages. The 21T series, 21NT, 21PT, 21MT-1, and 21MT-2, represent a mammary tumor progression series derived from the same patient (35) . The breast tumor cell lines ZR-75-1, MCF-7, BT-474, BT-549, T-47D, the MDA-MB series, including 157, 231, 361, 435, 436, and 468, and the immortalized normal cell line MCF-1OA were obtained from the American Type Culture Collection (Rockville, MD). All cell lines were cultured on plastic in DFCI-1 medium (34).
Differential Display (DD) Analysis DD was performed as described (29, 36, 37) to compare (1) normal, senescent, and quiescent 76N breast cells, (2) 76N normal and MDA-MB-435 breast tumor cells, or (3) normal sorted luminal epithelial, myoepithelial, and MDA-MB-435 breast tumor cells. RNA was extracted by the Cs cushion centrifugation method (38) . DD polymerase chain reactions (PCR) were performed using combinations of three 21 -bp anchor primers LH-T11N and twelve 18-bp LH-AP or ten 20-to 21-bp extended OPA arbitrary primers (36) . PCR products were electrophoresed using the GenomyxLR programmable sequencer (Genomyx, Foster City, CA).
Two ln a3 gene tags were selected as DD bands that were up-regulated in senescent cells and down-regulated in quiescent cells derived from the normal 76N breast cell strain. They were cloned as described (22 (29) . Two of these, ,33-A and ,B3-B, were cloned and sequenced as described (37) .
Northern Analysis
Northern blotting was performed as described previously (39) . Ten micrograms of total cellular RNA was electrophoresed on agarose gels and transferred to nylon membranes. Membranes were hybridized overnight at 42°C then washed three times, 15 min per wash, in 2X SSC with 0.1% SDS at 500C.
Southern Analysis of Genomic DNA Southern blotting was performed as described previously (39) after digesting high-molecularweight DNA isolated from cultured cells with HindlIl. DNA was processed for Southern blotting and hybridized to a mixture of three probes (a2-B, a3-C, and a3-D), which together cover 43% of the LAMA3 gene (Fig. 1) .
Metabolic Labeling and Immunoprecipitation
Metabolic labeling and immunoprecipitation were performed as described previously (40) using the ln a3-specific monoclonal antibody BM-2 (also called BM165) (6) Tags below mRNAs were generated by RT/PCR using primers designed to hybridized to published sequences (a3-C, a3-D, 'y2-A) or cloned from an expression library (a3-cDNA) (42, 43, 57) . The total lengths of 5532 for the In a3 and 5200 for the In y2 transcript account for all sequences reported (7, 42, 43, 57) . The 3930 bp of In 133 is as reported (58). 96-well format and then hybridizing membranes with 32P-labeled cDNA prepared in parallel from RNA extracted from comparison cell types. The procedure was performed as described elsewhere (29) . Breast tumor and adjacent normal tissue specimens of approximately 100 mg were obtained immediately following mastectomy or lumpectomy and frozen in liquid N2. Thawed tissue was minced into pieces of approximately 1 mm3, then homogenized in 3 ml GUT-,BME solution (4 M guanidine isothiocyanate, 25 mM NaCitrate, 7 Al/ml f-mercaptoethanol, pH 7) using 3 to 4 strokes of a teflon pestle Dounce. RNA was extracted by the Cs cushion centrifugation method (38 Figure 1 . Three additional In a3 gene tags were also obtained for use as control probes. The a3-C and a3-D tags were produced by RT-PCR from 76N RNA using synthetic primers designed to hybridize at the indicated locations. The 5' primer of a3-C is predicted to specifically recognize the a3EpA transcript (42) . This transcript is the smaller of two produced from the LAMA3 gene. a3-cDNA represents a 570 bp region of the In a3 cDNa, from nucleotide 706-1276 (42) . A In y2 tag, y2-A, was prepared by RT-PCR from 76N RNA using two primers designed to hybridize to the indicated locations of the In y2 cDNA (Fig. 1) . Both primers were designed to recognize only the longer of two different transcripts produced from the LAMC3 (42, 43 (45) . Expres- (Fig. 3B) .
Expression of ln /33 mRNA was assayed in 14 breast tumor cell lines using the /33-A probe.
Expression was reduced in all tumor cell lines tested compared to that of the normal cells (Fig. 3A, B) (Fig. 3D) Immunoprecipitation assays were performed to determine whether In-5 protein levels reflect mRNA levels. Cultured 70N normal breast epithelial cells and MDA-MB-435 breast tumor cells were grown to 50% confluence and then metabolically labeled with 35S-cysteine and -methionine. Spent medium and detergent-extracted cell/basement membrane layers were precipitated with BM-2, an antibody specific to ln a3 (6), 6F12, an antibody specific to ln f33 (41), or no antibody. Immunoprecipitations were performed prior to disruption of the disulfide-linked ln-5 heterotrimer, and hence each chain-specific antibody pulled down all of the ln-5 chains present in complexes. The individual chains were subsequently separated by boiling in fME, denatured in detergent, and resolved by acrylamide gel electrophoresis. Both the spent media and the cell monolayers were subjected to immunoprecipitation.
From the cell monolayer fraction of normal breast 70N cells, which also includes insoluble secreted basement membrane components, both antibodies precipitated proteins with molecular weights corresponding to the ln a3 (190 kD), j33 (140 kD), and 'y2 (155 kD) chains (6) (Fig. 4) . Low levels of the processed a3 doublet (160 kD)
. M and y2 (105 kD) chains were also present. Bands corresponding to these molecular weights were not present in control precipitations performed without antibody. From 70N medium, immunoprecipitated proteins had the molecular weights expected for the intact and processed a3 chains, the ,33 chain, and the intact and processed 'y2 chain. In 70N medium, the a3 and y2 chains were both partially processed (i.e., approximately 80% of a3 and 60% of y2 was present in processed forms). Processing of the a3 and y2 chains has previously been observed in cell culture. The medium of cultured keratinocytes contains ln-5 with a totally processed a3 chain and a partially processed y2 chain (41) , whereas colon cells produce unprocessed ln-5 (49). Hence, processing occurs to different extents in different cell types. These processing events have been shown to alter the functional consequences of ln-5 (11, 20) .
In contrast to the readily observed ln-5 chains produced by the normal breast cells, only faint bands were observed following immunoprecipitation of MDA-MB-435 breast carcinoma cells (Fig. 4) . In immunoprecipitations of the MDA-MB-435 cellular fraction, very low levels of the processed 160 kD j3 chain were observed following immunoprecipitation with the a3-specific antibody. No ln-5 proteins could be seen to be specifically immunoprecipitated by the /3 antibody. No ln-S was detected in the spent medium.
Ln-5 mRNA Expression in Quiescent and Senescent Cells Since senescence has been described as a growth state that suppresses tumorigenesis (30-32), Northern analysis was performed to examine ln-5 mRNA expression in senescent, quiescent, and actively growing 76N breast epithelial cells. Expression of ln a3 was markedly reduced in quiescent cells and increased in senescent cells relative to activity growing cells (Fig. 5A) . Results identical to those obtained with the a3-A probe were obtained using a3-B, a3-C, a3-D, and a3-cDNA as probes (data not shown). Very strong up-regulation was also observed for y2 mRNA in senescent cells (Fig. 5A) . Expression of /33 mRNA was modulated similarly to a3, though to a lesser degree. To further investigate the decrease in ln a3 expression in quiescent cells and the increase in senescent cells, time courses for both were examined. Ln a3 mRNA levels decreased by a factor of 100 as cells became more confluent (Fig. 5B) and increased 20-fold as cells aged (Fig. SC) .
Discussion
In previous studies, we have compared a variety of breast epithelial cell types and cell growth conditions using DD, and identified and verified over a hundred different differentially expressed genes (28, 29) . In an effort to identify genes that confer the normal breast epithelial phenotype, we looked for genes expressed in normal breast epithelial cells and down-regulated in breast tumor cells. Many of the identified down-regulated genes are known to be involved in cell adhesion and communication events. For example, genes down-regulated in breast tumor cells included the basement membrane protein fibronectin, the cell membrane-associated proteins caveolin, a6 integrin, protocadherin, and connexins 26 and 43, as well as the protease inhibitors al antichymotrypsin, plasminogen activator inhibitor PAI-2, cystatins A and M, elafin, and maspin. These proteins are all believed to be important in producing or maintaining stable cellular adhesion and intercellular communication. The isolation of ln-S as a part of this study links it with these normal-specific genes and implies that it plays a role in maintaining the phenotype of the normal breast epithelial cell.
The results presented here show that ln-S mRNA expression is down-regulated in breast tumor cells. A trend was observed for decreased expression of ln-S as tumors progressed. Expression levels tended to be lower in cell lines derived from later-stage, metastatic tumors than in cell lines derived from nonmetastatic primary tumors. In comparison, expression levels of all three ln-S mRNAs were high in normal breast epithelial cells, especially the MCF-1 OA cell line and immunomagnetically sorted normal breast luminal epithelial cells. These are relevant normal cell types for comparison with breast tumor cells, since both display molecular markers and morphological characteristics of normal luminal epithelial cells (44, 47) , the cell type to which breast carcinomas are most similar (46, 50) . Ln a3 and 133 mRNAs also tended to be expressed at lower levels in patient breast tumor specimens relative to adjacent nontumor breast tissue. Further, the ln-S mRNAs were up-regulated at senescence, which has been described as a growth state that functions to suppress tumorigenesis (30) (31) (32) 19 20 Passage number 21 22 Fig immunostaining with an antibody specific to In y2 showed elevated levels of expression, particularly in the invasive cells at the growing edge of the tumor (15, 22, 23) . Studies of tumor cell lines derived from stomach, tongue, and cervical carcinomas showed secretion of ladsin, a molecule recently found to be identical to ln-5 (12, 18, 19) . In contrast, In-5 levels in basal cell and prostate carcinomas have been reported to be reduced relative to levels of surrounding normal tissue (24) (25) (26) . We propose that the characteristic increase or decrease of In-5 expression in carcinomas derived from different tissue types may reflect different roles of the molecule in the different tissues.
Processing of the In a3 and y2 chains was observed to occur in cultured normal breast epithelial cells. Approximately 90% of the soluble In a3 and y2 was processed and 10% of the cell-associated In a3 and y2 was processed. Ln-5 a3 was processed from a 190 kD to a 160 kD form, while y2 was processed from a 155 kD to a 105 kD form. Similar processing of the a3 and y2 chains has been observed previously for keratinocytes (41) . Ln-5 processing appears to be highly significant in determining its function, though the precise effects of the different processing events in the context of the in vivo cellular environment are not yet clear. Ln y2 processing by the matrix metalloprotease MMP-2 to generate an 80 kD form has been shown to shift the In-5 matrix from a stationary to a migratory substrate for breast epithelial cells, apparently by exposing a cryptic migratory signal (1 ) . In contrast, In a3 is processed by tPA to generate a 160 kD molecule capable of nucleating hemidesmosome assembly and inhibiting cell motility (20) . Consistent with our observation of a 160 kD a3 chain and no 80 kD -y2 chain, 76N cells are not highly motile under culture conditions identical to those of our study (56) . In comparison, the breast tumor cell line MDA-MB-435, which we find does not produce detectable levels of In-5, is highly motile.
Processing of the In-5 chains occurs to different extents in different tissues. In the present study of breast cells, In a3 and y2 were both partially processed to 165 and 105 kD forms, respectively. In cultured keratinocytes, virtually all In a3 is processed, whereas In y2 is present in both processed and unprocessed forms (1) . In colon tumors, however, neither the In a3 nor the y2 chain are found in their processed form (49) . It has been suggested that the characteristic absence of hemidesmosomes in colon tumors may result from the absence of these forms of . Differential processing of the ln-5 chains in different tissues may determine the role the molecule plays in normal cellular processes and hence may impact the direction in which its expression is altered in tumors.
